Severity and patterns of blood-nerve barrier breakdown in patients with chronic inflammatory demyelinating polyradiculoneuropathy: Correlations with Clinical subtypes

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Shimizu, Fumitaka ^a   Sawai, Setsu ^b   Sano, Yasuteru ^a   Beppu, Minako ^b   Misawa, Sonoko ^b   Nishihara, Hideaki ^a   Koga, Michiaki ^a   Kuwabara, Satoshi ^b   Kanda, Takashi ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CLAUDIN 5; TIGHT JUNCTION PROTEIN; CLDN5 PROTEIN, HUMAN;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD NERVE BARRIER; CELLULAR PARAMETERS; CLINICAL ARTICLE; CONTROLLED STUDY; DEMYELINATION; DISABILITY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; DISTAL ACQUIRED DEMYELINATING SYMMETRIC NEUROPATHY; FEMALE; HUMAN; HUMAN CELL; MALE; MEDIAN NERVE; MEMBRANE DAMAGE; MICROVASCULAR ENDOTHELIAL CELL; MOTOR NERVE CONDUCTION; MULTIFOCAL ACQUIRED DEMYELINATING SENSORY AND MOTOR NEUROPATHY; PERIPHERAL NERVE; PHENOTYPE; POLYRADICULONEUROPATHY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TRANSENDOTHELIAL ELECTRICAL RESISTANCE; BLOOD; CLASSIFICATION; COMPARATIVE STUDY; ENDOTHELIUM CELL; IMPEDANCE; METABOLISM; NONPARAMETRIC TEST; PATHOPHYSIOLOGY; PHYSIOLOGY; WESTERN BLOTTING;

BLOOD-NERVE BARRIER; BLOTTING, WESTERN; CLAUDIN-5; ELECTRIC IMPEDANCE; ENDOTHELIAL CELLS; HUMANS; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING; STATISTICS, NONPARAMETRIC; TIGHT JUNCTION PROTEINS;

EID: 84905666107     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0104205     Document Type: Article

References (25)

1. Vallat JM, Sommer C, Magy L (2010) Chronic inflammatory demyelinating polyradiculoneuropathy: diagnostic and therapeutic challenges for a treatable condition. Lancet Neurol 9: 402-412.
2. Hughes R (2010) Chronic Inflammatory Demyelinating Polyradiculoneuropathy. J Clin Immunol 30: S70-73.
3. Van den Bergh PY, Hadden RD, Bouche P, Cornblath DR, Hahn A, et al (2010) European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society - first revision. Eur J Neurol 17: 356-363.
4. (1991) Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Neurology 41: 617-618.
5. Barohn RJ, Kissel JT, Warmolts JR, Mendell JR (1989) Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria. Arch Neurol 46: 878-884. (Pubitemid 19199372)
6. Saperstein DS, Amato AA, Wolfe GI, Katz JS, Nations SP, et al (1999) Multifocal acquired demyelinating sensory and motor neuropathy: the Lewis-Sumner syndrome. Muscle Nerve 22: 560-566. (Pubitemid 29214420)
7. Viala K, Renié L, Maisonobe T, Béhin A, Neil J, et al (2004) Follow-up study and response to treatment in 23 patients with Lewis-Sumner syndrome. Brain 127: 2010-2017. (Pubitemid 39150259)
8. Katz JS, Saperstein DS, Gronseth G, Amato AA, Barohn RJ (2000) Distal acquired demyelinating symmetric neuropathy. Neurology 54: 615-620. (Pubitemid 30082927)
9. Saperstein DS, Katz JS, Amato AA, Barohn RJ (2001) Clinical spectrum of chronic acquired demyelinating polyneuropathies. Muscle Nerve 24: 311-324. (Pubitemid 32172706)
10. Kuwabara S, Misawa S (2011) Chronic inflammatory demyelinating polyneuropathy: Clinical subtypes and their correlation with electrophysiology. Clin Exp Neuroimmunol 2: 41-48.
11. Kanda T, Numata Y, Mizusawa H (2004) Chronic inflammatory demyelinating polyneuropathy: decreased claudin-5 and relocated ZO-1. J Neurol Neurosurg Psychiatry 75: 765-769. (Pubitemid 38526691)
12. Kanda T (2013) Biology of the blood-nerve barrier and its alteration in immune mediated neuropathies. J Neurol Neurosurg Psychiatry 84: 208-212.
13. Ubogu EE (2013) The molecular and biophysical characterization of the human blood-nerve barrier: current concepts. J Vasc Res 50: 289-303.
14. Kuwabara S, Ogawara K, Misawa S, Mori M, Hattori T (2002) Distribution patterns of demyelination correlate with clinical profiles in chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry 72: 37-42. (Pubitemid 34073093)
15. Kuwabara S, Misawa S, Mori M, Tamura N, Kubota M (2006) Long term prognosis of chronic inflammatory demyelinating polyneuropathy: a five year follow up of 38 cases. J Neurol Neurosurg Psychiatry 77: 66-70. (Pubitemid 43022693)
16. Abe M, Sano Y, Maeda T, Shimizu F, Kashiwamura Y, et al (2012) Establishment and characterization of human peripheral nerve microvascular endothelial cell lines: a new in vitro blood-nerve barrier (BNB) model. Cell Struct Funct 37: 89-100.
17. Hughes RA, Newsom-Davis JM, Perkin GD, Pierce JM (1978) Controlled trial prednisolone in acute polyneuropathy. Lancet 2: 750-753. (Pubitemid 9034500)
18. Shimizu F, Omoto M, Sano Y, Mastui N, Miyashiro A, et al (2014) Sera from patients with multifocal motor neuropathy disrupt the blood-nerve barrier. J Neurol Neurosurg Psychiatry 85: 526-537.
19. Magda P, Latov N, Brannagan TH 3rd, Goldfarb A, Chin RL, et al (2005) Multifocal acquired sensory and motor neuropathy: electrodiagnostic features. J Clin Neuromuscul Dis 7: 10-18. (Pubitemid 41248470)
20. Van den Berg L, Hays AP, Nobile-Orazio E, Kinsella LJ, Manfredini E, et al (1996) Anti-MAG and anti-SGPG antibodies in neuropathy. Muscle Nerve 19: 637-643. (Pubitemid 26120173)
21. Chassande B, Léger JM, Younes-Chennoufi AB, Bengoufa D, Maisonobe T, et al (1998) Peripheral neuropathy associated with IgM monoclonal gammopathy: correlations between M-protein antibody activity and clinical/ electrophysiological features in 40 cases. Muscle Nerve 21: 55-62. (Pubitemid 28041681)
22. Hadden RD, Nobile-Orazio E, Sommer C, Hahn A, Illa I, et al (2006) European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of paraproteinaemic demyelinating neuropathies: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol 13: 809-818. (Pubitemid 44124676)
23. Larue S, Bombelli F, Viala K, Neil J, Maisonobe T, et al (2011) Non-anti-MAG DADS neuropathy as a variant of CIDP: clinical, electrophysiological, laboratory features and response to treatment in 10 cases. Eur J Neurol 18: 899-905.
24. Mygland A, Monstad P (2003) Chronic acquired demyelinating symmetric polyneuropathy classified by pattern of weakness. Arch Neurol 2003; 60: 260-264. (Pubitemid 36193972)
25. Katz JS, Saperstein DS (2001). Asymmetric Acquired Demyelinating Polyneuropathies: MMN and MADSAM. Curr Treat Options Neurol 3: 119-125.